Primary |
Asthma |
45.5% |
Multiple Allergies |
18.2% |
Allergic Asthma |
9.1% |
Allergic Rhinitis |
9.1% |
Rhinitis Allergic |
9.1% |
Upper Respiratory Tract Congestion |
9.1% |
|
Screaming |
14.3% |
Agitation |
7.1% |
Mental Disorder |
7.1% |
Night Sweats |
7.1% |
Nightmare |
7.1% |
Personality Disorder |
7.1% |
Product Substitution Issue |
7.1% |
Rash |
7.1% |
Skin Discolouration |
7.1% |
Sleep Terror |
7.1% |
Social Avoidant Behaviour |
7.1% |
Swelling |
7.1% |
Tearfulness |
7.1% |
|
Secondary |
Asthma |
42.9% |
Product Used For Unknown Indication |
35.7% |
Irritable Bowel Syndrome |
7.1% |
Menorrhagia |
7.1% |
Osteoporosis |
7.1% |
|
Vomiting |
28.6% |
Mental Disorder |
14.3% |
Muscle Spasms |
14.3% |
Sleep Disorder |
14.3% |
Thrombosis |
14.3% |
Ventricular Asystole |
14.3% |
|
Concomitant |
Product Used For Unknown Indication |
51.1% |
Asthma |
11.1% |
Hypersensitivity |
4.4% |
Rheumatoid Arthritis |
4.0% |
Gastrooesophageal Reflux Disease |
3.4% |
Hypertension |
3.2% |
Pain |
3.1% |
Crohn's Disease |
2.8% |
Chronic Obstructive Pulmonary Disease |
2.5% |
Depression |
2.3% |
Blood Cholesterol Increased |
1.4% |
Psoriasis |
1.4% |
Anxiety |
1.3% |
Blood Pressure |
1.2% |
Psoriatic Arthropathy |
1.2% |
Bipolar Disorder |
1.2% |
Multiple Sclerosis |
1.2% |
Cough |
1.1% |
Diabetes Mellitus |
1.1% |
Prophylaxis |
1.0% |
|
Sinusitis |
8.9% |
Vomiting |
6.9% |
Nausea |
5.9% |
Pain |
5.9% |
Pruritus |
5.9% |
Rash |
5.9% |
Weight Increased |
5.9% |
Injection Site Pain |
5.0% |
Nasopharyngitis |
5.0% |
Product Quality Issue |
5.0% |
Weight Decreased |
5.0% |
Wheezing |
5.0% |
Drug Ineffective |
4.0% |
Pain In Extremity |
4.0% |
Pneumonia |
4.0% |
Therapeutic Response Decreased |
4.0% |
Tremor |
4.0% |
Urinary Tract Infection |
4.0% |
Anaemia |
3.0% |
Insomnia |
3.0% |
|